A Study of Tarceva (Erlotinib) in Patients With Locally Advanced, Metastatic or Recurrent Non-Small Cell Cancer Who Present Epidermal Growth Factor Receptor Mutations

Clinical trial NCT01372384 · COMPLETED

Trial details

NCT number

NCT01372384

Sponsor

Hoffmann-La Roche

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2012-01-01

Primary completion

2014-01-01

Enrollment

6

View on ClinicalTrials.gov